.jpg "Jernigan Capital (NYSE: JCAP)")
Raymond James analyst Jonathan Hughes maintained a Buy rating on Jernigan Capital (JCAP) today and set a price target of $24. The company’s shares opened today at $21.77, close to its 52-week high of $22.05.
According to TipRanks.com, Hughes is a 4-star analyst with an average return of 4.1% and a 56.7% success rate. Hughes covers the Financial sector, focusing on stocks such as MedEquities Realty Trust, Sabra Healthcare REIT, and Omega Healthcare.
Jernigan Capital has an analyst consensus of Strong Buy, with a price target consensus of $24, a 10.2% upside from current levels. In a report issued on November 28, KeyBanc also maintained a Buy rating on the stock with a $23 price target.
.
See today’s analyst top recommended stocks >>
Based on Jernigan Capital’s latest earnings release for the quarter ending September 30, the company reported a quarterly net profit of $15.87 million. In comparison, last year the company had a net profit of $4.4 million.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Jernigan Capital, Inc. is a real estate investment company, which engages in the provision of debt and equity capital. Its investments include mortgage loans typically coupled with equity interests as well as outright ownership of self-storage facilities. The company was founded by Dean Jernigan in October 1, 2014 and is headquartered in Memphis, TN.
